In particular, we proposed that at least five TRP members (namely, TRPM8, TRPV6, TRPC6, TRPV2 and TRPA1) could be of particular interest in PCa therapy since their expression and function define and modulate specific stages of PCa progression (for a review see [5]). This evidence concerns the gene TRPC6 and posterior cortical atrophy.